Daunorubicin + Cytarabine + Venetoclax in de Novo AML

Clinical trial NCT06697327 · ENROLLING_BY_INVITATION

Trial details

NCT number: NCT06697327
Sponsor: Anhui Medical University
Status: ENROLLING_BY_INVITATION
Phase: Not Applicable
Study type: INTERVENTIONAL

Leukemia, Myeloid, Acute Acute Myeloid Leukemia

Start date: 2025-02-01
Primary completion: 2025-08-01
Enrollment: 94

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.